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Abstract 
Purpose: To investigate the expression of miR-1254 in 5 astrocytoma cell lines, and the mechanism 
involved.  
Methods: Total RNA was isolated by RNeasy RNA isolation kit while cDNA was prepared by RevertAid 
cDNA synthesis kit. The transcripts were analysed by real-time polymerase chain reaction (RT-PCR).  
Transfection of miR-1254 was carried out using FuGENE HD (Promega). Apoptosis was determined by 
DAPI, acridine orange (AO)/ethidium bromide (EB) and annexin V/PI double staining. Cell migration and 
invasion were investigated by wound healing and Martigel invasion assays, respectively. Protein 
expression was measured by western blotting. 
Results: Expression of miR-1254 was significantly down-regulated in the astrocytoma cell lines when 
compared to normal astrocyte cells (p < 0.05). Ectopic expression of miR-1254 in astrocytoma SW 1088 
cells inhibited cell proliferation via initiation of apoptosis and cell cycle arrest. Over-expression of miR-
1254 also led to significant decrease in cell migration and invasion of SW 1088 astrocytoma cells (p < 
0.05).  
Conclusion: The results show that the expression of miR-1254 is down-regulated in astrocytoma cell 
lines, but over-expression of miR-1254 inhibits proliferation of the cell lines via cell cycle arrest and 
apoptosis. Thus, miR-1254 has promising potential for use in the treatment of brain tumour. 
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 Micro RNAs (miRNAs) are small, non-coding 
RNA molecules that play vital roles in gene 
silencing. These miRNAs are about 18 - 25 
nucleotides in length and they control protein 
synthesis by targeting mRNAs through 
complementary binding [1]. The expression of 
miRNAs is often changed by diverse human 
disease conditions which include, but are not 
limited to, cancer [2]. Indeed, miRNAs are 
considered important in cancer. There are strong 
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evidence for the involvement of miRNAs in 
proliferation, metastasis, angiogenesis, migration 
and invasion of cancer cells [2].  
 
It has been reported that miRNAs can control 
these processes at the site of their origin or at 
sites remote from their sites of origin. The 
miRNAs influence the pathophysiology of diverse 
types of cancers [3]. The expression of miRNAs 
may either be up-regulated or down-regulated in 
cancerous tissues. However, it is has been 
reported that miRNAs show distinct types of 
expression profiles in different cancer types. The 
expression of miRNA may be up-regulated in one 
cancer type, but it may be down-regulated in 
other type [4]. Micro RNAs have been associated 
with tumorigenesis, in which they act as 
suppressors or oncogenes [5].  
 
Several miRNAs have also been implicated in 
development of drug resistance in cancer cells. 
Among the miRNAs, miR-1254 has been shown 
to play crucial function in suppression of cell 
migration in several types of cancers such as 
colorectal cancer, adenocarcinoma carcinoma 
and lung cancer [6]. However, the expression 
profile of miR-1254 in brain tumour has not been 
investigated. In particular, its role in the 
development of the bone tumours has not been 
studied.  Brain tumour which is often aggressive 
and rapidly-spreading, refers to an abnormal 
mass or growth in any region of the brain. It can 
be life-threatening, depending on the type, size, 
volume, location and origin [7]. The present study 
was therefore carried out to determine the 
expression of miR-1254 in five different 





Chemicals, reagents and cell cultures 
 
All reagents were obtained from Sigma-Aldrich 
Co. (St. Louis, MO, USA). Primary and 
secondary antibodies were obtained from Santa 
Cruz Biotechnology Inc. (Santa Cruz, CA, USA). 
Five human astrocytoma cell lines (CCF-STTG1, 
SW 1088, SW 178, U-87 M and U-118 M) were 
obtained from Type Culture Collection of Chinese 
Academy of Sciences, Shanghai, China. The 
cells were grown in RPMI-1640 medium 
containing 10 % fetal bovine serum (FBS) and 
100 U/mL (each) of penicillin and streptomycin, 
in a humidified atmosphere containing 5 % CO2. 
 
RNA isolation and synthesis of cDNA 
 
RNA was extracted from the five astrocytoma cell 
lines using TRIzol (Invitrogen) as per the 
manufacturer’s protocol. Quality check of RNA 
samples was done by measuring absorbance 
using NanoDrop® ND-1000 spectrophotometer 
(NanoDrop Technologies), and also by 
separation on 1% agarose gel. DNA 
contamination was removed by DNase I 
(Fermentas) treatment. Thereafter, cDNA 
synthesis was done with the help of RevertAid 
cDNA synthesis kit (Fermentas). 
 
Quantification of relative expression of miR-
1254 
 
The expression profile of miR-1254 was studied 
using quantitative RT-PCR in the five 
astrocytoma cell lines (CCF-STTG1, SW 1088, 
SW 178, U-87 M and U-118 M) and normal 
human astrocytes. The reaction was performed 
in a total volume of 20 μl. The reaction mixture 
contained 10 μL of 2X SYBR Green Master Mix, 
0.2 μM primers and 100 ng of cDNA. The cycling 
conditions were 95 °C for 20 s, followed by 40 
cycles at 95 °C for 15 s and 58 °C for 1 min. 
Actin amplification was used as control to 




For transfection of miR-1254, its upstream and 
downstream flanking sequences were amplified 
with the help of a genomic PCR. This was 
followed by cloning in pMSCv-pur vector. 
Thereafter the vector containing miR-1254 and 
the empty vector (used as negative control) were 
transfected into the SW 178 astrocytoma cells 
with help of FuGENE HD (Promega) as per the 
manufacturers’ protocol. 
 
Cell viability assay 
 
Cell viability was assessed spectrophotometri-
cally using MTT assay. Cultured SW 1088 cells 
transfected with pMSCv-pur vector containing 
miR-1254 or empty vector were seeded at a 
density of 1.2 × 104 to 1.5 × 104 in 96-well micro-
titre plates. This was followed by the addition of 
MTT solution to the wells. Absorbance at 570 nm 





SW1088 astrocytoma cells were seeded at a 
density of 2 ਀ 105 cells/well in 6-well plates. The 
cells were then stained with a mixture of AO and 
EB. The stained cells were examined under the 
fluorescent microscope. Another batch of cells 
was incubated with DAPI, and thereafter the cells 
were washed with PBS and fixed in 10 % 
formaldehyde. The DAPI-stained cells were 
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examined by fluorescent microscopy. The 
SW1088 brain tumour astrocytoma cells were 
also subjected to annexin V/PI and examined by 
flow cytometry. 
 
Cell cycle analysis 
 
In the estimation of the distribution of SW 1088 
astrocytoma cells in different phases of cell 
cycle, the cells were fixed in 70 % ethanol for 
about 1 hour and then PBS-washed. The cells 
were then suspended in a solution of PI (50 
µl/mL) and RNase1 (250 µg/mL). This was 
followed by incubation for a period of 25 min at 
room temperature. Cell cycle analysis was 
carried out in fluorescence-activated cell sorting 
cater-plus cytometer using 10, 000 cells/group. 
 
Matrigel invasion assay 
 
Invasion was determined using Matrigel®-coated 
invasion chambers (BD Biosciences). The SW 
1088 cells (transfected with pMSCv-pur vector 
containing miR-1254 or the empty vector) that 
reached the lower surface of the membrane were 
stained with crystal violet (CV).  Images of CV-
stained cells were captured by a phase contrast 
microscope. The resultant crystal violet complex 
was dissolved in 10 % acetic acid, and the extent 
of invasion was determined by measuring 
absorbance at 600 nm. 
 
Western blot analysis 
 
Total protein from SW 1088 cells (transfected 
with pMSCv-pur vector containing miR-1254 or 
the empty vector) was isolated in RIPA lysis 
buffer. Equal volumes of the proteins from each 
sample were run on SDS PAGE. This was 
followed by transference to a polyvinylidene 
fluoride membrane, and blocking with 5 % non-
fat milk, and incubation at room temperature for 1 
h. The membranes were then treated with 
specific primary antibody at 4 °C for 20 hrs.  
Thereafter, the membranes were washed in 
washing buffer, and incubated with secondary 
antibody for 1 h.  The protein bands were then 





All data are expressed as mean ± SD. 
Statistically significant differences between 
groups were determined by one-way ANOVA 
and Tukey’s post hoc test using GraphPad prism 
7 software. Values of p < 0.05 were considered 





MiR-1254 was down-regulated in astrocytoma 
cell lines 
 
The expression of miR-1254 was significantly (p 
< 0.05) down-regulated in all the astrocytoma cell 
lines (Figure 1). The lowest expression was 
observed in CCF-STTG1, while the highest 
expression was observed in SW 178 cell line. 
Astrocytoma cell line SW 1088 showed moderate 





Figure 1: Expression of miR-1254 brain tumor 
astrocytoma cell lines and normal astrocytes as 
determined quantitative RT-PCR. The experiments 
were carried out thrice in triplicates and presented as 
mean ± SD (*p < 0.05) 
 
Ectopic expression of miR-1254 decreased 
cell viability through apoptosis 
 
To find out the role of miR-1254 in astrocytoma, 
the SW1088 cells were transfected with either 
empty vector or with vector containing miR-1254. 
The results showed that cells transfected with 
miR-1254 exhibited less cell viability when 
compared with the empty vector, control cells 
(Figure 2). These results indicate that ectopic 
expression of miR-1254 in SW1088 cells 
inhibited the viability of the cells. In order to 
investigate the underlying mechanism of the 
viability inhibition, DAPI, EB/OR and Annexin-
V/PI staining were carried. The results obtained 
showed that the over-expression of miR-1254 in 
SW 1088 cells triggered apoptosis (Figure 3). 
Thus, miR-1254 reduced cell viability in miR-
1254 via induction of apoptosis. 
 
Ectopic expression of miR-1254 triggered 
G2/M cell cycle arrest 
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The effect of miR-1254 on cell cycle distribution 
of SW 1088 astrocytoma cells was investigated. 
It was observed that cells that received vector 
containing miR-1254 showed increased number 
of cells in G2/M phase of the cell cycle, when 
compared with cells that received empty vector 
(Figure 4). These results suggest that miR-1254 
exerted anti-proliferative effects, partly via 




Figure 2: Cell viability of miR-1254 transfected and 
empty vector transfected SW 1088 cell line as 
determined by MTT assay. The experiments were 
carried out thrice in triplicates and presented as mean 
± SD (*p < 0.05) 
 
Ectopic expression of miRNA-1254 inhibited 
cell migration and invasion 
 
Since, microRNAs have been reported to play 
important role in controlling the migration and 
invasion of cancer cells, the effect of miR-1254 
on the cell migration and invasion of SW 1088 
astrocytoma cells was investigated. The results 
of wound healing assay indicated that ectopic 
expression of miR-1254 significantly reduced 
migration of the SW 1088 cells after 20 h. Within 
the same period, the relative migration in the 
control cells with empty vector was 31 %, when 
compared with 19 % migration in the cells that 
over-expressed miR-1254 (Figure 5A & 5B). 
Results of Martigel invasion assay showed that 
invasion in the astrocytoma SW 1088 that 
received vector was only 60 %, relative to control 
SW 1088 cells that received empty vector (Figure 
5C and 5D). These results clearly indicate that 
miR-1254 over-expression in SW 1088 cells 
inhibited cell migration and invasion. 
 
 
Figure 3: MiR-1254 overexpression triggers apoptosis 
as determined by DAPI, EB/AO and annexin V/PI 
double staining (n = 3) 
 
 
Figure 4: MiR-1254 overexpression triggers G2/M cell cycle arrest as determined by flow cytometery (n = 3) 
 
Li et al 
Trop J Pharm Res, January 2018; 17(1): 39 
 
 
Figure 5: MiR-1254 overexpression inhibits (A) cell 
migration (B) cell invasion as observed in wound 
healing and boyden chamber assays respectively.The 
experiments were carried out thrice in triplicates and 




MicroRNAs are small RNA molecules that do not 
code for any protein. They are involved in diverse 
cellular functions, and control some important 
processes such as cell cycle progression and 
regulation of gene expression [8]. These 
microRNAs have gained tremendous importance 
as therapeutic agents for the treatment of cancer 
[9]. They have been reported to show unique 
expression in wide array of cancers. The 
microRNAs have been reported to control cell 
proliferation, apoptosis, cell cycle arrest, 
metastasis, angiogenesis, migration and invasion 
of several types of cancer cells [10]. Hence, they 
are considered as important therapeutic targets 
for the treatment of cancers. Against this 
backdrop, the current study was designed to 
investigate the expression of miR-1254 in 
astrocytoma cell lines, and the role of miR-1254 
in these cells.  
 
It was observed that expression of miR-1254 was 
highly down-regulated in all the astrocytoma cell 
lines studied. The results are well supported by 
previous studies wherein miR-1254 was reported 
to be down-regulated in several types of cancers, 
including lung cancer [11,12]. In order to 
investigate the function of miR-1254 in 
astrocytoma, miR-1254 was transfected into 
SW1088 astrocytoma cells. The results showed 
that ectopic expression of miR-1254 induced 
apoptosis in SW 1088 astrocytoma cells, as was 
evident from the DAPI, EB/AO and annexin V/PI 
staining. Previously, miR-1254 was also reported 
to inhibit the proliferation of cancer cells which 
include but are not limited to colorectal cancer 
[11,12]. 
 
MicroRNAs have also been reported to play a 
key role in progression of the cancer cells 
through different phases of the cell cycle [13]. 
The results of the present study showed that 
ectopic expression of miR-1254 caused G2/M 
cell arrest in the SW 1088 astrocytoma cells. 
Earlier investigations carried out on miR-1254 
have revealed that it inhibited cell migration and 
invasion of cancer cells [14]. For instance, miR-
1254 has been reported to inhibit the migration 
and invasion of colorectal cancer by inhibiting 
PSMD10 [15]. Therefore, the effect of miR-1254 
on the migration and invasion of SW 1008 
astrocytoma cells was also investigated in the 
current study. The results showed that miR-1254 
significantly inhibited migration and invasion of 
astrocytoma cells. The results strongly indicate 
that miR-1254 may be a therapeutic target for the 





The findings of this study show that miR-1254 is 
highly down-regulated in astrocytoma cell lines. 
Ectopic expression of miR-1254 causes inhibition 
of cell proliferation via induction of apoptosis and 
cell cycle arrest while miR-1254 inhibits migration 
and invasion of the astrocytoma cell lines. 
Therefore, miR-1254 is a potential therapeutic 
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